NASS comments on a variety of policy and scientific topics on behalf of its membership and patients.  Any questions about these documents should be directed to Pam Hayden.

Review and Recommendation Statements

NASS Comments

• NASS Comments to US Senate on Health IT Adoption – 5/9/13
  
  
• NASS Comments on Senate HELP Committee Draft Proposal on Pharmaceutical Compounding – 5/3/13
  
  
• NASS Comments on Draft Comparative Effectiveness Review: Spinal Fusion for Treating Painful Lumbar Degenerated Discs or Joints – 12/18/12
  
  
• NASS Comments on the 2013 Medicare Physician Fee Schedule Proposed
  Rule – 9/4/12
  
  
• NASS Signs Alliance for Specialty Medicine Letter on the 2013 Medicare Physician Fee Schedule Proposed Rule – 9/4/12
  
  
• NASS Signs on to American Medical Association Comment Letter to CMS on Return of Medicare Overpayments – 4/16/12
  
  
• NASS Signs on to Alliance of Specialty Medicine Comment Letter to CMS on Return of Medicare Overpayments – 4/16/12
  
  
• NASS Supports Reclassification Petition for Posterior Cervical Pedicle and Lateral Mass Screws – 2/6/12
  
  
• NASS Signs On to Alliance for Specialty Medicine Letter to CMS on the 2012 Medicare Fee Schedule Final Rule – 1/3/12
  
  
• NASS Submits Comment Letter to CMS on the 2012 Medicare Fee Schedule Final
  Rule – 1/3/12
  
  
• NASS Signs Alliance for Specialty Medicine Letter to MedPAC on the SGR – 9/26/11
  
  
• NASS Comments on the 2012 Medicare Physician Fee Schedule Proposed
  Rule – 8/30/11
  
  
• NASS Signs Alliance for Specialty Medicine Letter on the 2012 Medicare Physician Fee Schedule Proposed Rule – 8/30/11
  
  
• NASS Signs Alliance for Specialty Medicine Letter to CMS on the Availability of Medicare Data for Performance Measurement – 8/8/11
  
  
• Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule Accounting of Disclosures Under the Health Information Technology for Economic and Clinical Health (HITECH) Act – 8/1/11
  
  
• NASS Comments to CMS on the Electronic Prescribing Incentive Program – 7/25/11
  
  
• NASS Signs Alliance for Specialty Medicine Letter to CMS on the Electronic Prescribing Incentive Program – 7/25/11
  
  
• NASS Joins Alliance for Specialty Medicine in Commenting on ACOs – 6/13/11
  
  
• NASS Comments on Medicare Shared Savings Program: Accountable Care Organizations – 6/6/11
  
  
• NASS Comments to AMA/CMS on Opportunities for Increasing the Effectiveness and Lowering the Burden of CMS Measurement and Data Collection Activities – 4/4/11
  
  
• Emergency Medical Treatment and Labor Act: Applicability to Hospital and Critical Access Hospital Inpatients and Hospitals With Specialized Capabilities – 3/28/11
  
  
• NASS Joins Alliance of Specialty Medicine in Commenting on Plans for the 2012 Physician Quality Reporting System (PQRS) – 2/17/2011
  
  
• NASS Joins Alliance of Specialty Medicine in Commenting on Final Changes to the Medicare Physician Fee Schedule for CY 2011 – 1/5/11
  
  
• NASS Joins Alliance of Specialty Medicine in Commenting on CMS' Plans for Physician Compare Website – 11/29/10
  
  
• NASS Comments on Noridian's Vertebroplasty Draft Coverage Policy – 9/6/10
  
  
• NASS Joins Alliance of Specialty Medicine in Commenting on 2011 Medicare Fee Schedule Proposed Rule – 8/24/10
  
  
• NASS Comments on 2011 Medicare Fee Schedule Proposed Rule – 8/24/10
  
  
• Signs Alliance for Specialty Medicine Letter on FDA Transparency Initiative: Draft Proposals for Public Comment Regarding Disclosure Policies of the U.S. Food and Drug Administration – 8/4/10
  
  
• NASS & AAOS Comment on AHRQ's BMP Technology Assessment – 5/6/10
  
  
• NASS Signs AMA Letter on EHR Incentive Program – 5/3/10
  
  
• NASS Joins AAOS and Others in Comment to FDA on Strengthening the CDRH 510(k) review process – 3/22/10
  
  
• NASS Signs Alliance for Specialty Medicine Letter to FDA Re: 510(k) Review Process Within the CDRH – 3/22/10
  
  
• NASS Comment on FDA 510(k) Process – 3/18/10
  
  
• NASS Signs on to AMA Letter on Medicare Participation – 3/16/10
  
  
• NASS Signs Alliance of Specialty Medicine Letter on EHR Incentive Program – 3/15/10
  
  
• Public Health Effectiveness of the FDA 510(k) Clearance Process: Addition of a Practicing Surgeon – 03/15/10
  
  
• NASS Signs Alliance of Specialty Medicine letter to FDA re: Incorporating Emerging Science into Regulatory Decision Making – 2/26/10
  
  
• NASS Comment: Newly Released Vertebroplasty RCTs: A Tale of Two Trials Summary – 10/13/09
  
  
• Washington State Approves Coverage for Lumbar and Cervical Artificial Discs – 10/30/08
  
  
• Medicare Program; Proposed Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2009 Rates—Non-payment of Never Events and Oxiplex Add-on Payment – 6/16/08
  
  
• Multisociety Comment on Draft Key Questions: Washington State Health Care Authority Health Technology Assessment on Artificial Discs – 4/10/08
  
  
• NASS Comment: Patient Safety and Quality Improvement Proposed Rule (RIN 0919-AA01) – 4/14/08